Thomas Bayer
Thomas Bayer
Professor, University Medicine Goettingen
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide–the first step of a fatal cascade
O Wirths, G Multhaup, TA Bayer
Journal of neurochemistry 91 (3), 513-520, 2004
Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model
C Casas, N Sergeant, JM Itier, V Blanchard, O Wirths, N Van Der Kolk, ...
The American journal of pathology 165 (4), 1289-1300, 2004
Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice
TA Bayer, S Schäfer, A Simons, A Kemmling, T Kamer, R Tepests, ...
Proceedings of the National Academy of Sciences 100 (24), 14187-14192, 2003
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease
S Jawhar, A Trawicka, C Jenneckens, TA Bayer, O Wirths
Neurobiology of aging 33 (1), 196. e29-196. e40, 2012
Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice
O Wirths, G Multhaup, C Czech, V Blanchard, S Moussaoui, G Tremp, ...
Neuroscience letters 306 (1-2), 116-120, 2001
Evidence for activation of microglia in patients with psychiatric illnesses
TA Bayer, R Buslei, L Havas, P Falkai
Neuroscience letters 271 (2), 126-128, 1999
Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the" two hit hypothesis."
TA Bayer, P Falkai, W Maier
Journal of psychiatric research, 1999
Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease
C Schmitz, BPF Rutten, A Pielen, S Schäfer, O Wirths, G Tremp, C Czech, ...
The American journal of pathology 164 (4), 1495-1502, 2004
Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice
V Blanchard, S Moussaoui, C Czech, N Touchet, B Bonici, M Planche, ...
Experimental neurology 184 (1), 247-263, 2003
Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease
M Heverin, N Bogdanovic, D Lütjohann, T Bayer, I Pikuleva, L Bretillon, ...
Journal of lipid research 45 (1), 186-193, 2004
Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease
S Scheuermann, B Hambsch, L Hesse, J Stumm, C Schmidt, D Beher, ...
Journal of Biological Chemistry 276 (36), 33923-33929, 2001
A genetic variation of the inflammatory cytokine interleukin‐6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease
A Papassotiropoulos, M Bagli, F Jessen, TA Bayer, W Maier, ML Rao, ...
Annals of Neurology: Official Journal of the American Neurological …, 1999
Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier
SE Storck, S Meister, J Nahrath, JN Meißner, N Schubert, A Di Spiezio, ...
The Journal of clinical investigation 126 (1), 123-136, 2016
Review of immunological and immunopathological findings in schizophrenia
M Rothermundt, V Arolt, TA Bayer
Brain, behavior, and immunity 15 (4), 319-339, 2001
Key factors in Alzheimer's disease: β‐amyloid precursor protein processing, metabolism and intraneuronal transport
TA Bayer, O Wirths, K Majtényi, T Hartmann, G Multhaup, K Beyreuther, ...
Brain Pathology 11 (1), 1-11, 2001
Intracellular accumulation of amyloid-Beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease
TA Bayer, O Wirths
Frontiers in aging neuroscience 2, 8, 2010
Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease
S Jawhar, O Wirths, TA Bayer
Journal of Biological Chemistry 286 (45), 38825-38832, 2011
No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study.
P Falkai, WG Honer, S David, B Bogerts, C Majtenyi, TA Bayer
Neuropathology and applied neurobiology 25 (1), 48-53, 1999
Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
O Wirths, H Breyhan, H Cynis, S Schilling, HU Demuth, TA Bayer
Acta neuropathologica 118 (4), 487-496, 2009
Disturbed gyrification of the prefrontal region in male schizophrenic patients: a morphometric postmortem study
K Vogeley, T Schneider-Axmann, U Pfeiffer, R Tepest, TA Bayer, ...
American Journal of Psychiatry 157 (1), 34-39, 2000
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20